Determining surrogate endpoints predictive of overall survival in patients treated with bevacizumab for advanced ovarian cancer — A multi-institutional study

✍ Scribed by S. Ueda; A. Alvarez-Secord; W. Huh; T. Tillmanns; K. Moore; R. Previs; L. Perry; T. Kiet; C. Tian; J. Chan

• Book ID: 113963743
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 64 KB
• Volume: 125
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2011.12.188